Beat AML is transforming treatment for people with acute myeloid leukemia through a collaborative targeted treatment approach New trial arm will evaluate lomonitinib, Eilean’s precision therapy designed to address AML treatment resistance DOVER, Del., June 11, 2024 /PRNewswire/ — Eilean…